Tejara Capital Ltd Invests $1.87 Million in Humana Inc. $HUM

Tejara Capital Ltd purchased a new stake in Humana Inc. (NYSE:HUM) in the third quarter, Holdings Channel reports. The firm purchased 7,200 shares of the insurance provider’s stock, valued at approximately $1,873,000.

Other institutional investors also recently bought and sold shares of the company. Elevation Point Wealth Partners LLC bought a new position in Humana in the second quarter worth approximately $32,000. Mather Group LLC. purchased a new position in shares of Humana in the 3rd quarter valued at $34,000. AlphaCore Capital LLC bought a new position in shares of Humana in the 2nd quarter worth $39,000. Private Wealth Management Group LLC raised its position in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its stake in shares of Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on HUM shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research report on Thursday, January 22nd. Bank of America raised their price target on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Sanford C. Bernstein restated an “outperform” rating and set a $344.00 price target on shares of Humana in a research note on Tuesday, January 6th. Wells Fargo & Company downgraded shares of Humana from an “overweight” rating to a “cautious” rating in a report on Wednesday, January 7th. Finally, Wolfe Research lifted their target price on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $293.21.

Humana Trading Down 0.8%

Humana stock opened at $195.15 on Friday. The stock has a 50-day moving average price of $256.45 and a 200 day moving average price of $264.02. The company has a market capitalization of $23.47 billion, a price-to-earnings ratio of 18.29, a price-to-earnings-growth ratio of 1.62 and a beta of 0.45. Humana Inc. has a 52 week low of $191.39 and a 52 week high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the prior year, the company earned $4.16 EPS. Humana’s quarterly revenue was up 11.1% on a year-over-year basis. Sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.